Shares of Builders FirstSource surged 7.1% to $71.15 today, clawing back a chunk of last week's brutal selloff after the nation's largest building-materials supplier slashed its 2026 outlook on July 30. The rebound, fueled by a broader market rally, raises a critical question: is this a legitimate bottom or just a dead-cat bounce in a worsening housing cycle?
Earnings Missed and the Full-Year Bar Dropped Hard. Q2 net sales fell 8.8% year-over-year to $3.9 billion, while adjusted EPS plunged 50.8% to $1.17, missing the Street's $1.28 estimate.
Management cut full-year revenue guidance to $14.0–$14.8 billion from $14.6–$15.6 billion — well below the analyst consensus of $15.11 billion.
Adjusted EBITDA guidance fell to $1.0–$1.2 billion from $1.1–$1.5 billion. Translation: the company now expects to earn significantly less cash from its operations than it told investors just three months ago.
Every End Market Is Shrinking at Once. Single-family starts dropped 8.1%, multifamily fell 9.7%, and repair-and-remodel slipped 1.8%.
Value-added product sales — higher-margin items like manufactured trusses and windows — declined 11.1%.
Gross margins contracted 260 basis points to 28.1%, and adjusted EBITDA margins fell 350 points to 8.5%. When every revenue stream is declining simultaneously, cost-cutting alone can only do so much.
The Cost-Cutting Playbook Is Aggressive but the Balance Sheet Is Stretching. Management identified $115 million in annualized cost cuts, including an additional $40 million announced on the call.
The company has consolidated 36 facilities this year and 91 over roughly three years. But net debt relative to trailing EBITDA — a measure of how much the company owes compared to what it earns — rose to 3.6x from 2.3x a year ago. That rising leverage limits future buybacks and deal-making flexibility.
Wall Street Cut Targets but Mostly Held Buy Ratings. Post-earnings, UBS slashed its price target to $88 from $122, Oppenheimer cut to $90 from $110, and Baird dropped to $75 from $95 — suggesting analysts see upside from current levels but far less than before. At $71.15, BLDR sits just above its 52-week low of $65.10, more than half off its $151 high.
Analysts project EPS rebounding 31.7% in fiscal 2027 , but that bet hinges entirely on a housing recovery that mortgage rates have yet to unlock.